IRIS Accounts Production v25.1.4.42 12196253 Board of Directors 1.10.23 30.9.24 30.9.24 false true false false true false Ordinary 1.00000 63385 45300 59287 55625 59823 37540 62849 63385 iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 12196253 2023-09-30 12196253 2024-09-30 12196253 2023-10-01 2024-09-30 12196253 2022-09-30 12196253 2022-10-01 2023-09-30 12196253 2023-09-30 12196253 ns15:EnglandWales 2023-10-01 2024-09-30 12196253 ns14:PoundSterling 2023-10-01 2024-09-30 12196253 ns10:Director1 2023-10-01 2024-09-30 12196253 ns10:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 12196253 ns10:SmallEntities 2023-10-01 2024-09-30 12196253 ns10:AuditExempt-NoAccountantsReport 2023-10-01 2024-09-30 12196253 ns10:SmallCompaniesRegimeForDirectorsReport 2023-10-01 2024-09-30 12196253 ns10:SmallCompaniesRegimeForAccounts 2023-10-01 2024-09-30 12196253 ns10:AbridgedAccounts 2023-10-01 2024-09-30 12196253 ns10:OrdinaryShareClass1 2023-10-01 2024-09-30 12196253 ns10:Director2 42 2023-09-30 12196253 ns10:Director2 42 2022-09-30 12196253 ns10:Director2 42 2023-10-01 2024-09-30 12196253 ns10:Director2 42 2022-10-01 2023-09-30 12196253 ns10:Director2 42 2024-09-30 12196253 ns10:Director2 42 2023-09-30 12196253 ns10:Director2 2023-10-01 2024-09-30 12196253 ns10:RegisteredOffice 2023-10-01 2024-09-30 12196253 ns5:CurrentFinancialInstruments 2024-09-30 12196253 ns5:CurrentFinancialInstruments 2023-09-30 12196253 ns5:Non-currentFinancialInstruments 2024-09-30 12196253 ns5:Non-currentFinancialInstruments 2023-09-30 12196253 ns5:ShareCapital 2024-09-30 12196253 ns5:ShareCapital 2023-09-30 12196253 ns5:RetainedEarningsAccumulatedLosses 2024-09-30 12196253 ns5:RetainedEarningsAccumulatedLosses 2023-09-30 12196253 ns5:FurnitureFittings 2023-10-01 2024-09-30 12196253 ns5:ComputerEquipment 2023-10-01 2024-09-30 12196253 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-09-30 12196253 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2023-09-30 12196253 ns5:BetweenOneTwoYears ns5:Non-currentFinancialInstruments 2024-09-30 12196253 ns5:BetweenOneTwoYears ns5:Non-currentFinancialInstruments 2023-09-30 12196253 ns5:Non-currentFinancialInstruments ns5:BetweenTwoFiveYears 2024-09-30 12196253 ns5:Non-currentFinancialInstruments ns5:BetweenTwoFiveYears 2023-09-30 12196253 ns10:OrdinaryShareClass1 2024-09-30 12196253 1 ns10:Director1 2023-09-30 12196253 1 ns10:Director1 2022-09-30 12196253 1 ns10:Director1 2023-10-01 2024-09-30 12196253 1 ns10:Director1 2022-10-01 2023-09-30 12196253 1 ns10:Director1 2024-09-30 12196253 1 ns10:Director1 2023-09-30

REGISTERED NUMBER: 12196253 (England and Wales)

Unaudited Financial Statements for the Year Ended 30 September 2024

for

Callisto Life Science Partners Ltd

| Callisto Life Science Partners Ltd (Registered number: 12196253) |

Contents of the Financial Statements

for the Year Ended 30 September 2024

Page |

| Company Information | 1 |

| Abridged Statement of Financial Position | 2 |

| Notes to the Financial Statements | 4 |

| Callisto Life Science Partners Ltd |

Company Information

for the Year Ended 30 September 2024

| DIRECTORS: | R Leach

| Mrs A R Leach

| REGISTERED OFFICE: | 14 The Oaks

| Clews Road

| Redditch

| Worcestershire

| B98 7ST

| REGISTERED NUMBER: | 12196253 (England and Wales)

| ACCOUNTANTS: | Davies Archytas Accountants Ltd

| 14 The Oaks

| Clews Road

| Redditch

| Worcestershire

| B98 7ST

| Callisto Life Science Partners Ltd (Registered number: 12196253) |

Abridged Statement of Financial Position

30 September 2024

| 30.9.24 | 30.9.23 |

| Notes | £ | £ | £ | £ |

FIXED ASSETS

Tangible assets | 4 | 790 |  | 1,309 |  |

CURRENT ASSETS

Debtors | 96,853 |  | 94,211 |  |

Cash at bank | 5,208 |  | 7,496 |  |

102,061 |  | 101,707 |  |

CREDITORS

Amounts falling due within one year | 67,028 |  | 70,450 |  |

NET CURRENT ASSETS | 35,033 |  | 31,257 |  |

TOTAL ASSETS LESS CURRENT LIABILITIES | 35,823 |  | 32,566 |  |

CREDITORS

Amounts falling due after more than one year | 30,970 |  | 32,242 |  |

NET ASSETS | 4,853 |  | 324 |  |

CAPITAL AND RESERVES

Called up share capital | 6 | 2 |  | 2 |  |

Retained earnings | 4,851 |  | 322 |  |

SHAREHOLDERS' FUNDS | 4,853 |  | 324 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

| Callisto Life Science Partners Ltd (Registered number: 12196253) |

Abridged Statement of Financial Position - continued

30 September 2024

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Statement of Financial Position for the year ended 30 September 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19 February 2025 and were signed on its behalf by:

R Leach - Director

| Callisto Life Science Partners Ltd (Registered number: 12196253) |

Notes to the Financial Statements

for the Year Ended 30 September 2024

1. | STATUTORY INFORMATION

| Callisto Life Science Partners Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| The presentation currency of the financial statements is the Pound Sterling (£).

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Turnover

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

| Fixtures and fittings | - | 15% on reducing balance

| Computer equipment | - | 33% on cost

| Taxation

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 2 (2023 - 2 ) .

| Callisto Life Science Partners Ltd (Registered number: 12196253) |

Notes to the Financial Statements - continued

for the Year Ended 30 September 2024

4. | TANGIBLE FIXED ASSETS

| Totals

£ |

| COST

| At 1 October 2023

| and 30 September 2024 | 9,338 |  |

| DEPRECIATION

| At 1 October 2023 | 8,029 |  |

| Charge for year | 519 |  |

| At 30 September 2024 | 8,548 |  |

| NET BOOK VALUE

| At 30 September 2024 | 790 |  |

| At 30 September 2023 | 1,309 |  |

5. | LOANS

| An analysis of the maturity of loans is given below:

| 30.9.24 |  | 30.9.23

£ | £ |

| Amounts falling due within one year or on demand:

| Bank loans | 5,705 |  | 5,705 |  |

| Amounts falling due between one and two years:

| Bank loans - 1-2 years | 5,705 |  | 5,705 |  |

| Amounts falling due between two and five years:

| Bank loans - 2-5 years | 25,265 |  | 26,537 |  |

6. | CALLED UP SHARE CAPITAL

| Allotted, issued and fully paid:

| Number: | Class: | Nominal | 30.9.24 |  | 30.9.23

| value: | £ | £ |

| 2 | Ordinary | £1 | 2 |  | 2 |  |

7. | DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

| The following advances and credits to directors subsisted during the years ended 30 September 2024 and 30 September 2023:

| 30.9.24 |  | 30.9.23

£ | £ |

| R Leach and Mrs A R Leach

| Balance outstanding at start of year | 63,385 |  | 45,300 |  |

| Amounts advanced | 59,287 |  | 55,625 |  |

| Amounts repaid | (59,823 | ) | (37,540 | ) |

| Amounts written off | - |  | - |  |

| Amounts waived | - |  | - |  |

| Balance outstanding at end of year | 62,849 |  | 63,385 |  |

| Callisto Life Science Partners Ltd (Registered number: 12196253) |

Notes to the Financial Statements - continued

for the Year Ended 30 September 2024

7. | DIRECTORS' ADVANCES, CREDITS AND GUARANTEES - continued

| The overdrawn director's loan account is included within debtors. It is an interest free unsecured loan to the directors, Mr R Leach and Mrs A R Leach.

8. | ULTIMATE CONTROLLING PARTY

| During the financial year, the controlling parties were the directors, Mr R Leach and Mrs A R Leach.

| From 15th September 2024, the controlling party was Mr R Leach by virtue of his 100% holding of the issued share capital of the company.